Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Healthy Extracts CEO Discusses Health and Wellness on Here’s To Your Health With Joshua Lane
      Health

      Healthy Extracts CEO Discusses Health and Wellness on Here’s To Your Health With Joshua Lane

      June 14, 2022
      Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting Firm
      Health

      Statera Biopharma Announces BF Borgers CPA PC as Independent Registered Public Accounting Firm

      June 14, 2022
      Soleno Therapeutics Presents Long Term Data for DCCR Showing Metabolic and Body Composition Improvements in Patients with PWS
      Health

      Soleno Therapeutics Presents Long Term Data for DCCR Showing Metabolic and Body Composition Improvements in Patients with PWS

      June 13, 2022
      GeoVax Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development
      Health

      GeoVax Appoints Recognized Industry Leader John W. Sharkey, PhD as Vice President, Business Development

      June 13, 2022
      Fulcrum Therapeutics Announces Proof-of-Concept for FTX-6058 in Sickle Cell Disease Based on Initial Data from the Ongoing Phase 1b Trial
      Health

      Fulcrum Therapeutics Announces Proof-of-Concept for FTX-6058 in Sickle Cell Disease Based on Initial Data from the Ongoing Phase 1b Trial

      June 10, 2022
      Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)
      Health

      Amarin Receives Positive Recommendation from United Kingdom’s (UK) National Institute for Health and Care Excellence (NICE) for Reimbursement of VAZKEPA® (icosapent ethyl)

      June 10, 2022
      Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
      Health

      Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      June 10, 2022
      BIMI Announces Entering into a $5 million Stock Purchase Agreement
      Health

      BIMI Announces Entering into a $5 million Stock Purchase Agreement

      June 10, 2022
      Kintara Therapeutics to Present at the JMP Securities Life Sciences Conference
      Health

      Kintara Therapeutics to Present at the JMP Securities Life Sciences Conference

      June 10, 2022
      Trevena to Participate at the JMP Securities Life Sciences Conference
      Health

      Trevena to Participate at the JMP Securities Life Sciences Conference

      June 10, 2022
      « 1 … 251 252 253 254 255 256 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026